An individual with a healthy phenotype in spite of a pathogenic LDL receptor mutation (C240F)
(1999) In Clinical Genetics 55(5). p.332-339- Abstract
- Familial hypercholesterolemia (FH) is caused by a defect in the function of the low density lipoprotein (LDL) receptor and inherited in an autosomal, codominant way. In this study we present a 13-year-old girl, compound heterozygote for the LDL receptor mutations C240F and Y167X. Fibroblasts from the patient showed very low cholesterol esterification rate, LDL uptake, and degradation compared to normal fibroblasts (< 2%, 8%, and < 2%, respectively). The C240F mutant was expressed in LDL receptor deficient CHOMldlA7 cells. Analysis of cell extracts by immunoblotting demonstrated delayed processing of the mutated LDL receptor, which was accumulated as a precursor protein of normal size. A high molecular weight form of the receptor was... (More)
- Familial hypercholesterolemia (FH) is caused by a defect in the function of the low density lipoprotein (LDL) receptor and inherited in an autosomal, codominant way. In this study we present a 13-year-old girl, compound heterozygote for the LDL receptor mutations C240F and Y167X. Fibroblasts from the patient showed very low cholesterol esterification rate, LDL uptake, and degradation compared to normal fibroblasts (< 2%, 8%, and < 2%, respectively). The C240F mutant was expressed in LDL receptor deficient CHOMldlA7 cells. Analysis of cell extracts by immunoblotting demonstrated delayed processing of the mutated LDL receptor, which was accumulated as a precursor protein of normal size. A high molecular weight form of the receptor was also detectable in these cells, which probably reflects cross-linking through the unpaired cysteine residue in the binding domain. Cells expressing the C240F mutant protein were unable to mediate uptake and degradation of LDL. The two siblings of the index case also carried the C240F mutation, but surprisingly one of them (a 17-year-old brother) showed no signs of hypercholesterolemia. This observation is consistent with the view that there may be cholesterol lowering mechanisms that can be activated, perhaps by mutations in known or hitherto unknown genes. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/1115794
- author
- Ekström, Ulf LU ; Abrahamson, Magnus LU ; Florén, Claes-Henrik LU ; Tollig, H ; Wettrell, Göran GWE LU ; Nilsson, Gerd LU ; Sun, X M ; Soutar, A K and Nilsson-Ehle, Peter LU
- organization
- publishing date
- 1999
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- expression, LDL receptor, familial hypercholesterolemia, mutation, phenotype
- in
- Clinical Genetics
- volume
- 55
- issue
- 5
- pages
- 332 - 339
- publisher
- Wiley-Blackwell
- external identifiers
-
- pmid:10422803
- scopus:0033055179
- ISSN
- 0009-9163
- DOI
- 10.1034/j.1399-0004.1999.550506.x
- language
- English
- LU publication?
- yes
- id
- b197e8ea-b22c-4865-9df8-23397b21935a (old id 1115794)
- date added to LUP
- 2016-04-01 12:10:20
- date last changed
- 2024-01-08 10:58:50
@article{b197e8ea-b22c-4865-9df8-23397b21935a, abstract = {{Familial hypercholesterolemia (FH) is caused by a defect in the function of the low density lipoprotein (LDL) receptor and inherited in an autosomal, codominant way. In this study we present a 13-year-old girl, compound heterozygote for the LDL receptor mutations C240F and Y167X. Fibroblasts from the patient showed very low cholesterol esterification rate, LDL uptake, and degradation compared to normal fibroblasts (< 2%, 8%, and < 2%, respectively). The C240F mutant was expressed in LDL receptor deficient CHOMldlA7 cells. Analysis of cell extracts by immunoblotting demonstrated delayed processing of the mutated LDL receptor, which was accumulated as a precursor protein of normal size. A high molecular weight form of the receptor was also detectable in these cells, which probably reflects cross-linking through the unpaired cysteine residue in the binding domain. Cells expressing the C240F mutant protein were unable to mediate uptake and degradation of LDL. The two siblings of the index case also carried the C240F mutation, but surprisingly one of them (a 17-year-old brother) showed no signs of hypercholesterolemia. This observation is consistent with the view that there may be cholesterol lowering mechanisms that can be activated, perhaps by mutations in known or hitherto unknown genes.}}, author = {{Ekström, Ulf and Abrahamson, Magnus and Florén, Claes-Henrik and Tollig, H and Wettrell, Göran GWE and Nilsson, Gerd and Sun, X M and Soutar, A K and Nilsson-Ehle, Peter}}, issn = {{0009-9163}}, keywords = {{expression; LDL receptor; familial hypercholesterolemia; mutation; phenotype}}, language = {{eng}}, number = {{5}}, pages = {{332--339}}, publisher = {{Wiley-Blackwell}}, series = {{Clinical Genetics}}, title = {{An individual with a healthy phenotype in spite of a pathogenic LDL receptor mutation (C240F)}}, url = {{http://dx.doi.org/10.1034/j.1399-0004.1999.550506.x}}, doi = {{10.1034/j.1399-0004.1999.550506.x}}, volume = {{55}}, year = {{1999}}, }